Brief: Next Science Says Health Canada Has Given Licensing Approval For Xperiencetm
26/08/2022 02:14
Aug 26 (Reuters) - Next Science Ltd NXS.AX :
* HEALTH CANADA HAS GIVEN LICENSING APPROVAL FOR XPERIENCETM
TO BE
SOLD IN CANADA EFFECTIVE IMMEDIATELY
Source text for Eikon: ID:nASX2vs5WS
Further company coverage: NXS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Next Science
See all newsBrief: ASX Says Next Science Limited Will Be Removed From Official List
Brief: Next Science Says CEO & Managing Director I.V. Hall, and CFO Marc Zimmerman Resigned
Brief: Next Science Releases Quarterly Activity Report
Australia's Next Science surges on sale of assets for $50 million
Brief: Next Science To Sell Majority Of Assets